HLX07: Clinical Trials

3 trials of HLX07, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting, 1 unknown. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 1, Not yet recruiting 1, Unknown 1
Phase 21Not yet recruiting 1

Follow HLX07: new trials by email Literature Review of HLX07 trials Research Report on HLX07

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase Ib/II Study to Evaluate HLX43 Combined With HLX07 or Serplulimab in Patients With Advanced or Metastatic Colorectal Cancer
HLX43 dose 1 + HLX07, HLX43 dose 2 + HLX07, HLX43 dose 3 + Serplulimab - Colon Cancer Adenocarcinoma
Phase 1 / Phase 2Not yet recruitingShanghai Henlius Biotech1262026-01-312026-01-22
HLX07(Anti-EGFR mAb) in Patients With Advanced or Metastatic Solid Tumors
HLX07 - Solid Tumor
Phase 1UnknownShanghai Henlius Biotech242023-03-302022-05-05
An Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of HLX07,in Patients With Advanced Solid Cancers
HLX07, Acetaminophen, dexamethasone - Solid Tumour
Phase 1CompletedHenlix, Inc192016-09-012019-07-30

Conditions studied

Colonic Neoplasms (1)  ·  Neoplasm Metastasis (1)

Sponsors

Shanghai Henlius Biotech (2)  ·  Henlix, Inc (1)

Countries

China (2)  ·  Taiwan (1)  ·  United States (1)

Top investigators

Weidong Jiang, Ph.D. (1)

Results publications

PMID 33713216